This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of pharmaceutical agents. Its structure, featuring a trifluoromethyl group and a chiral center, makes it valuable for developing molecules with enhanced biological activity and selectivity. It is often employed in the creation of potential drug candidates targeting central nervous system disorders, such as anxiety, depression, or neurodegenerative diseases. Additionally, its unique stereochemistry allows for the exploration of enantioselective reactions, contributing to the development of more effective and safer therapeutic compounds. Researchers also leverage its properties in the design of enzyme inhibitors, particularly those involved in metabolic pathways or signal transduction processes.